Safety and Efficacy of Licaminlimab Ophthalmic Suspension for the Treatment of Dry Eye Disease (clinicaltrials.gov) - Nov 28, 2023 - P2 | N=120 | Not yet recruiting | Sponsor: Oculis | Initiation date: Aug 2023 ➔ Dec 2023
Trial initiation date • Dry Eye Disease • Ophthalmology
|